Novo Nordisk's pricing procedures while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of value gouging, declaring the stark distinction concerning U.S. prices and people in Europe and copyright.Novo Nordisk is involved with govt funded collaborative research tasks with other industrial and